Coinfection in the host can result in functional complementation between live vaccines and virulent virus

Virulence. 2022 Dec;13(1):980-989. doi: 10.1080/21505594.2022.2082645.

Abstract

One of the greatest achievements of the last century is the development of vaccines against viral diseases. Vaccines are essential for battling infectious diseases and many different formulations are available, including live attenuated vaccines. However, the use of live attenuated vaccines has the potential for adverse effects, including reversion of pathogenicity, recombination, and functional complementation in the host. Marek's disease is a serious disease in poultry controlled by live attenuated vaccines that has resulted in increased virulence over the decades. Recombination between circulating field viruses or vaccines is a proposed mechanism for the increase in virulence, however, complementation between vaccines and field strains has not been demonstrated in chickens. Here, we describe functional complementation of vaccines with virulent virus to functionally complement transmission and spread in the host. Using the natural virus-host model of Marek's disease in chickens, our results show dual infection of target cells in chickens with vaccine and virulent virus providing the opportunity for recombination or complementation to transpire. Interestingly, our controlled results showed no evidence of recombination between vaccine and virulent virus, but functional complementation occurred in two independent experiments providing proof for complementation during natural infection in vaccinated individuals. These results suggest complementation as a potential mechanism for vaccine-mediated viral evolution and the potential for complementation should be taken into consideration when developing novel vaccines.

Keywords: Marek’s disease; complementation; herpesvirus; transmission; vaccines.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Chickens
  • Coinfection*
  • Marek Disease* / prevention & control
  • Poultry Diseases*
  • Vaccines, Attenuated / genetics
  • Viral Vaccines* / genetics
  • Viruses*

Substances

  • Vaccines, Attenuated
  • Viral Vaccines

Grants and funding

This work was funded by Agriculture and Food Research Initiative Competitive Grant no. 2020-67015-21399 from the USDA National Institute of Food and Agriculture (to K.W.J.), and by USDA-NIFA AFRI grant no. 2019-67015-29262 as part of the joint USDA-NIFA-NIH Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species Program (to K.W.J.).